OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Will biopharma investment heat up and signal better fortunes for 2023?
Focus is on cash: who’s got it, who doesn’t, and what will it mean?
As fundamentals improve, potential rate plateau could ignite growth.
Biotech stocks and the indexes have staged an impressive recovery.
A look at the driving factors behind renewed optimism.
A summary of key takeaways from EY’s new Beyond Borders report.